Table 1.
Case No. | Neuropathological diagnosis | Gender | Age at death | PMI, h | Disease duration, year |
---|---|---|---|---|---|
1 | AD | F | 68 | 9 | 8 |
2 | AD | F | 59 | 14 | 9 |
3 | AD | M | 66 | 4 | 11 |
1 | CBD | M | 44 | 7 | Unknown |
2 | CBD | M | 52 | 8 | 4 |
3 | CBD | M | 56 | 15 | 6 |
1 | PSP | F | 63 | 6.5 | 5 |
2 | PSP | M | 74 | Unknown | Unknown |
3 | PSP | M | 65 | 13 | 10 |
4 | PSP | M | 78 | 23 | 9 |
5 | PSP | M | 71 | 14 | Unknown |
All human tauopathy cases used in the study, gender, age of death, post-mortem interval (PMI) (in hours), and disease duration (in years).